After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Indian speciality pharmaceutical firm Ajanta Pharma is understood to be eyeing a manufacturing operation in Ireland. The ...

The University of Pennsylvania, biotech firm BioNTech, and Osage University Partners, a venture capital firm in Bala Cynwyd, ...

Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology ...

This line of argument could resonate with other conservative groups in the European Parliament opposed to abortion ...

Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Katie Logan Spencer has a LOT going on right now on The Bold and the Beautiful. Overnight she became a married woman and ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest ...